CEP-28122, a Highly Potent and Selective Orally Active...

Molecular Cancer Therapeutics 2012 / 03 Vol. 11; Iss. 3

CEP-28122, a Highly Potent and Selective Orally Active Inhibitor of Anaplastic Lymphoma Kinase with Antitumor Activity in Experimental Models of Human Cancers

Cheng, M., Quail, M. R., Gingrich, D. E., Ott, G. R., Lu, L., Wan, W., Albom, M. S., Angeles, T. S., Aimone, L. D., Cristofani, F., Machiorlatti, R., Abele, C., Ator, M. A., Dorsey, B. D., Inghirami,
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
11
Language:
english
Journal:
Molecular Cancer Therapeutics
DOI:
10.1158/1535-7163.MCT-11-0776
Date:
March, 2012
File:
PDF, 988 KB
english, 2012
Conversion to is in progress
Conversion to is failed